Tharimmune CEO resigns; appoints Sireesh Appajosyula as new CEO, adds director

Canton Strategic Holdings, Inc.

CEO Randy Milby resigned for personal reasons; receives $133,500 settlement and accelerated vesting of unvested options, contingent on $3M+ financing.
Sireesh Appajosyula appointed CEO; employment agreement provides $285K base salary, 60% bonus target, 5-year term, severance benefits.
Vincent LoPriore, previously named Executive Chairman, entered employment agreement with same $285K base, bonus, and severance terms.
James Gordon Liddy appointed to the Board effective June 11, 2025.
Milby's unvested stock options vested immediately upon resignation.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Randy Milby

Chief Executive Officer and Director

CNTN · Canton Strategic Holdings, Inc.

Effective: 2025-06-11
Successor: Sireesh Appajosyula
Filed: Jun 11, 2025 23:59 UTC

Randy Milby pursuant to which he resigned for personal reasons from his positions as Chief Executive Officer and member of the Board of Directors, effective immediately.

Appointed

Sireesh Appajosyula

Chief Executive Officer

CNTN · Canton Strategic Holdings, Inc.

Effective: 2025-06-11
Filed: Jun 11, 2025 23:59 UTC

the Board appointed Sireesh Appajosyula as the Company’s Chief Executive Officer, effective immediately.

Appointed

James Gordon Liddy

Director

CNTN · Canton Strategic Holdings, Inc.

Effective: 2025-06-11
Filed: Jun 11, 2025 23:59 UTC

the Board appointed James Gordon Liddy as a member of the Board, effective immediately.

Source: SEC EDGAR

accession 0001641172-25-014753

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.